Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Marc-Antoine de La Vega"'
Autor:
Joseph Jelinski, Monika M. Kowatsch, Marc-Alexandre Lafrance, Alice Berger, Jannie Pedersen, Hiva Azizi, Yue Li, Florine Scholte, Alejandro Gomez, Natasha Hollett, Toby Le, Matthew Wade, Hugues Fausther-Bovendo, Marc-Antoine de La Vega, George Babuadze, Ara, Claude Lamarre, Trina Racine, Chil-Yong Kang, Xiao-Jian Yao, Galit Alter, Eric Arts, Keith R. Fowke, Gary P. Kobinger
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 2 (2023)
Despite the human immunodeficiency virus (HIV) pandemic continuing worldwide for 40 years, no vaccine to combat the disease has been licenced for use in at risk populations. Here, we describe a novel recombinant vesicular stomatitis virus (rVSV) vect
Externí odkaz:
https://doaj.org/article/ac4f6afa4e50490f8eb8b4863aced04d
Autor:
Marc-Antoine de La Vega, Efstathia Polychronopoulou, Ara XIII, Zhe Ding, Tong Chen, Qixing Liu, Jiaming Lan, Marie-Edith Nepveu-Traversy, Hugues Fausther-Bovendo, Mohammed F. Zaidan, Gary Wong, Gulshan Sharma, Gary P. Kobinger
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 1 (2023)
ABSTRACTDuring a pandemic, effective vaccines are typically in short supply, particularly at onset intervals when the wave is accelerating. We conducted an observational, retrospective analysis of aggregated data from all patients who tested positive
Externí odkaz:
https://doaj.org/article/1bba93e518ce4ac280d939edd7be6c03
Autor:
Alice Berger, Jannie Pedersen, Monika M. Kowatsch, Florine Scholte, Marc-Alexandre Lafrance, Hiva Azizi, Yue Li, Alejandro Gomez, Matthew Wade, Hugues Fausther-Bovendo, Marc-Antoine de La Vega, Joseph Jelinski, George Babuadze, Marie-Edith Nepveu-Traversy, Claude Lamarre, Trina Racine, Chil-Yong Kang, Bruno Gaillet, Alain Garnier, Rénald Gilbert, Amine Kamen, Xiao-Jian Yao, Keith R. Fowke, Eric Arts, Gary Kobinger
Publikováno v:
Vaccines, Vol 12, Iss 4, p 369 (2024)
Currently, no effective vaccine to prevent human immunodeficiency virus (HIV) infection is available, and various platforms are being examined. The vesicular stomatitis virus (VSV) vaccine vehicle can induce robust humoral and cell-mediated immune re
Externí odkaz:
https://doaj.org/article/c19284c469914bd5bcbe3e22da769431
Autor:
Alejandro M. Gomez, George (Giorgi) Babuadze, Marc-André Plourde-Campagna, Hiva Azizi, Alice Berger, Robert Kozak, Marc-Antoine de La Vega, Ara XIII, Maedeh Naghibosadat, Marie-Edith Nepveu-Traversy, Jean Ruel, Gary P. Kobinger
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-10 (2022)
Abstract In recent years, tattooing technology has shown promising results toward evaluating vaccines in both animal models and humans. However, this technology has some limitations due to variability of experimental evaluations or operator procedure
Externí odkaz:
https://doaj.org/article/572cc9afa15541998f90ad9f819ab826
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-5 (2022)
Abstract Following the identification of SARS-CoV-2, screening for air travel helped mitigate spread, yet lessons learned from a case study of air travel within Canada display enhanced techniques to better identify infected individuals, informing fut
Externí odkaz:
https://doaj.org/article/90d2ffe1da9c4264b20f530eca57b683
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Available therapeutics for autoimmune disorders focused on mitigating symptoms, rather than treating the cause of the disorder. A novel approach using adeno-associated virus (AAV) could restore tolerance to the autoimmune targets and provide
Externí odkaz:
https://doaj.org/article/46587e0ae2a64831ab66f65f12b4a139
Autor:
Hiva Azizi, Jason P. Knapp, Yue Li, Alice Berger, Marc-Alexandre Lafrance, Jannie Pedersen, Marc-Antoine de la Vega, Trina Racine, Chil-Yong Kang, Jamie F. S. Mann, Jimmy D. Dikeakos, Gary Kobinger, Eric J. Arts
Publikováno v:
Vaccines, Vol 11, Iss 5, p 977 (2023)
Vesicular stomatitis virus (VSV) remains an attractive platform for a potential HIV-1 vaccine but hurdles remain, such as selection of a highly immunogenic HIV-1 Envelope (Env) with a maximal surface expression on recombinant rVSV particles. An HIV-1
Externí odkaz:
https://doaj.org/article/5fb10575b302437c965355e5448185ca
Autor:
Bryan D. Griffin, Kar Muthumani, Bryce M. Warner, Anna Majer, Mable Hagan, Jonathan Audet, Derek R. Stein, Charlene Ranadheera, Trina Racine, Marc-Antoine De La Vega, Jocelyne Piret, Stephanie Kucas, Kaylie N. Tran, Kathy L. Frost, Christine De Graff, Geoff Soule, Leanne Scharikow, Jennifer Scott, Gordon McTavish, Valerie Smid, Young K. Park, Joel N. Maslow, Niranjan Y. Sardesai, J. Joseph Kim, Xiao-jian Yao, Alexander Bello, Robbin Lindsay, Guy Boivin, Stephanie A. Booth, Darwyn Kobasa, Carissa Embury-Hyatt, David Safronetz, David B. Weiner, Gary P. Kobinger
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-8 (2017)
Zika virus (ZIKV) can persist in human semen and sperm, which can result in sexual transmission. Here, Griffinet al. show that a DNA vaccine, expressing ZIKV pre-membrane and envelope proteins, protects mice from infection-associated damage to testes
Externí odkaz:
https://doaj.org/article/0c82ce7b193e4897a52f784c15fa050c
Autor:
Marc-Antoine de La Vega, Geoff Soule, Kaylie N. Tran, Kevin Tierney, Shihua He, Gary Wong, Xiangguo Qiu, Gary P. Kobinger
Publikováno v:
mSphere, Vol 3, Iss 5 (2018)
ABSTRACT Ebola virus (EBOV) has been responsible for sporadic outbreaks in Central Africa since 1976 and has the potential of causing social disruption and public panic as illustrated by the 2013–2016 epidemic in West Africa. Transmission of EBOV h
Externí odkaz:
https://doaj.org/article/b53ec316cd5e409dab3dac5fb4173d6d
Autor:
Kamalini Lokuge, Grazia Caleo, Jane Greig, Jennifer Duncombe, Nicholas McWilliam, James Squire, Manjo Lamin, Emily Veltus, Anja Wolz, Gary Kobinger, Marc-Antoine de la Vega, Osman Gbabai, Sao Nabieu, Mohammed Lamin, Ronald Kremer, Kostas Danis, Emily Banks, Kathryn Glass
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 10, Iss 3, p e0004498 (2016)
INTRODUCTION:The scale and geographical distribution of the current outbreak in West Africa raised doubts as to the effectiveness of established methods of control. Ebola Virus Disease (EVD) was first detected in Sierra Leone in May 2014 in Kailahun
Externí odkaz:
https://doaj.org/article/ab76be0a2ba0447ba3e9711dd051d3c8